Your browser doesn't support javascript.
loading
Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective.
Chan, Amy H Y; Pleasants, Roy A; Dhand, Rajiv; Tilley, Stephen L; Schworer, Stephen A; Costello, Richard W; Merchant, Rajan.
Affiliation
  • Chan AHY; Faculty of Medical and Health Sciences, University of Auckland, Auckland, 1023, New Zealand. a.chan@auckland.ac.nz.
  • Pleasants RA; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.
  • Dhand R; Division of Pulmonary and Critical Care Medicine, University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.
  • Tilley SL; Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.
  • Schworer SA; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.
  • Costello RW; Royal College of Surgeons Ireland, 123 St Stephen's Green, Dublin 2, D02 YN77, Ireland.
  • Merchant R; Dignity Health Woodland Clinic, 632 W Gibson Rd, Woodland, CA, USA.
Pulm Ther ; 7(2): 345-376, 2021 Dec.
Article de En | MEDLINE | ID: mdl-34379316
ABSTRACT
Impressive advances in inhalation therapy for patients with asthma and chronic obstructive pulmonary disease (COPD) have occurred in recent years. However, important gaps in care remain, particularly relating to poor adherence to inhaled therapies. Digital inhaler health platforms which incorporate digital inhalers to monitor time and date of dosing are an effective disease and medication management tool, promoting collaborative care between clinicians and patients, and providing more in-depth understanding of actual inhaler use. With advances in technology, nearly all inhalers can be digitalized with add-on or embedded sensors to record and transmit data quantitating inhaler actuations, and some have additional capabilities to evaluate inhaler technique. In addition to providing an objective and readily available measure of adherence, they allow patients to interact with the device directly or through their self-management smartphone application such as via alerts and recording of health status. Clinicians can access these data remotely and during patient encounters, to better inform them about disease status and medication adherence and inhaler technique. The ability for remote patient monitoring is accelerating interest in and the use of these devices in clinical practice and research settings. More than 20 clinical studies of digital inhalers in asthma or COPD collectively show improvement in medication adherence, exacerbation risk, and patient outcomes with digital inhalers. These studies support previous findings about patient inhaler use and behaviors, but with greater granularity, and reveal some new findings about patient medication-taking behaviors. Digital devices that record inspiratory flows with inhaler use can guide proper inhaler technique and may prove to be a clinically useful lung function measure. Adoption of digital inhalers into practice is still early, and additional research is needed to determine patient and clinician acceptability, the appropriate place of these devices in the therapeutic regimen, and their cost effectiveness. Video Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease A Scientific Perspective (MP4 74535 kb).
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Aspects: Patient_preference Langue: En Journal: Pulm Ther Année: 2021 Type de document: Article Pays d'affiliation: Nouvelle-Zélande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Aspects: Patient_preference Langue: En Journal: Pulm Ther Année: 2021 Type de document: Article Pays d'affiliation: Nouvelle-Zélande
...